Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy

Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy

Insulin resistance is characteristic of pregnancies where the mother shows metabolic alterations, such as preeclampsia (PE) and gestational diabetes mellitus (GDM), or abnormal maternal conditions such as pregestational maternal obesity (PGMO). Insulin signalling includes activation of insulin recep...

Full description

Bibliographic Details
Main Authors:	Roberto Villalobos-Labra, Luis Silva, Mario Subiabre, Joaquín Araos, Rocío Salsoso, Bárbara Fuenzalida, Tamara Sáez, Fernando Toledo, Marcelo González, Claudia Quezada, Fabián Pardo, Delia I. Chiarello, Andrea Leiva, Luis Sobrevia
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2017/5947859

Similar Items

The paradox of Akt -mTOR interactions
by: LAKSHMIPATHI eVADLAKONDA, et al.
Published: (2013-06-01)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
by: Kerstin Tiedemann, et al.
Published: (2017-05-01)

Akt and mTOR in B cell activation and differentiation
by: David A. Fruman, et al.
Published: (2012-08-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

Insulin is a key modulator of fetoplacental endothelium metabolic disturbances in gestational diabetes mellitus
by: Luis eSobrevia, et al.
Published: (2016-03-01)

Carcinoma da bexiga: via de sinalização PI3K/Akt/mTOR e inibidores do mTOR
by: Maria do Céu dos Santos Silva Costa
Published: (2019)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01)

Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
by: Bárbara Fuenzalida, et al.
Published: (2018-05-01)

Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
by: Choudhary Harsha, et al.
Published: (2020-05-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

Neuroligin 3 Regulates Dendritic Outgrowth by Modulating Akt/mTOR Signaling
by: Jing Xu, et al.
Published: (2019-11-01)

Akt1 enhances CA916798 expression through mTOR pathway.
by: Yu-Liang Wang, et al.
Published: (2013-01-01)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
by: Tasuku Matsuoka, et al.
Published: (2014-07-01)

The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas
by: Elias A. El Habr, et al.
Published: (2012-01-01)

Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
by: Makoto Taga, Eiji Hirooka, Toru Ouchi
Published: (2009-01-01)

MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
by: Nicola J Clegg, et al.
Published: (2011-03-01)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
by: Yu Zhang, et al.
Published: (2019-10-01)

SIL1 functions as an oncogene in glioma by AKT/mTOR signaling pathway
by: Xu H, et al.
Published: (2018-07-01)

Regulatory role of WW domain-containing oxidoreductase in Akt/mTOR signaling
by: Tzu-Ting Huang, et al.
Published: (2008)

Regulatory role of WW domain-containing oxidoreductase in Akt/mTOR signaling
by: Tzu-Ting Huang, et al.

Synthesis and evaluation of novel PI3-K-Akt-mTOR modulators
by: Gunn, Richard Martin
Published: (2010)

Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.
by: Weiyuan Wang, et al.
Published: (2014-01-01)

Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas
by: Ricardo Rivera-Soto, et al.
Published: (2021-06-01)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Regulates Neurite Outgrowth Through the Activation of Akt/mTOR and Erk/mTOR Signaling Pathways
by: Wen Wen, et al.
Published: (2020-09-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway.
by: Imane Lejri, et al.
Published: (2019-01-01)

Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
by: Jean-Michel Maury, et al.
Published: (2019-01-01)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
by: Salihanur Darici, et al.
Published: (2020-09-01)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
by: R. Reilly, et al.
Published: (2017-08-01)

The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
by: Hengchuan Su, et al.
Published: (2013-01-01)

Arctigenin Inhibits Glioblastoma Proliferation through the AKT/mTOR Pathway and Induces Autophagy
by: Yong’an Jiang, et al.
Published: (2020-01-01)

Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR
by: Kenneth Maiese
Published: (2013-01-01)

PI3K/Akt/mTOR signaling pathway and malignant hepatobiliary tumors
by: CHEN Xuxiao
Published: (2015-06-01)

mTOR Promotes Survival and Astrocytic Characteristics Induced by Pten/Akt Signaling in Glioblastoma
by: Xiaoyi Hu, et al.
Published: (2005-04-01)

Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
by: Hyera Kim, et al.
Published: (2020-04-01)

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
by: Forough Alemi Serej, et al.
Published: (2018-01-01)

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
by: Grabinski Nicole, et al.
Published: (2012-11-01)

Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition
by: Elizabeth M. MacDonald, et al.
Published: (2014-04-01)